Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
International initiative for neurodevelopmental disorders launched - The Pharma Times | Pharma & Health Care News Portal
Extras

International initiative for neurodevelopmental disorders launched


Dhaka, September 12, 2014 – 
 WHO and partners today stressed the need for a comprehensive and coordinated response to address the challenges of Autism Spectrum Disorders (ASD) in WHO’s South- East Asia Region. This was deliberated at an initiative launched by the Ministry of Health and Family Welfare, Government of Bangladesh, supported by the World Health Organization.

The initiative was launched at a side event held during the ongoing Sixty-seventh Session of the WHO Regional Committee for South-East Asia.

Autism spectrum disorders are a complex medical condition which comprise a range of developmental disorders. ASDs are characterized by lack of language development, impaired social communication, hypersensitivity to sensory stimulation, repetitive mannerisms and restricted interests. These, in turn, affect, a persons health, social, educational and economic functioning

While there is no proven cause for ASDs, there is growing evidence that these could be due to a gene-environment interaction, and that a genetic predisposition combines with some, as yet unknown external environmental factors, which cause ASD. However, no clear genetic defect or universally applicable environmental factors have been identified.

“We must empower families and communities with information and services to create a more inclusive world for children who suffer from ASD” said Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia. “There is an urgent need to develop innovative ways and embed appropriate interventions into health systems to reach the affected”.

The side event aimed to move forward an international partnership of Member States, nongovernmental organizations, international organizations and institutions, towards a Global initiative on ASD and other neurodevelopmental disorders. The partnership would work towards a more inclusive and integrated global community through enhanced services and programmes for persons suffering from ASD.

CCI Newswire

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

4 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago